Dr. Juan R. Jaramillo, MD

Dr. Jaramillo practices at Ascension St Vincent Hospital- Indianapolis in Indianapolis, Indiana.

Dr. Jaramillo's NPI, 1568579670, was assigned on August 24, 2006. Dr. Jaramillo holds Indiana license 01081538A.

Dr. Jaramillo's primary practice is Ascension St Vincent Hospital- Indianapolis, at 2001 W 86th St, Indianapolis, IN 46260 in Marion County. The practice phone is (317) 338-2345.

Dr. Jaramillo's primary practice is Ascension St Vincent Hospital- Indianapolis in Indianapolis, Indiana. Dr. Jaramillo is also affiliated with Parkview Regional Medical Center. The medical group on file is Ascension St. Vincent Stress Center. Dmand AI also links Dr. Jaramillo to 6 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Jaramillo practices. Vendor and product names are available with a free account.

Psychiatry is Dr. Jaramillo's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dmand AI has Dr. Jaramillo's licenses on file in 3 states: Indiana, Kentucky and Tennessee.

CMS data shows 220 Medicare services from Dr. Jaramillo across 3 procedure codes in 2024, for 141 Medicare patients. Medicare paid $18,057 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 141 Medicare patients who saw Dr. Jaramillo in 2024. The largest group is 65 to 74, with 58 patients. 75% of them have anxiety, and 75% have high blood pressure. 55% are also on Medicaid. Their average risk score is 2.52, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Jaramillo's median patient age at 63, with 63% women.

In 2024, Dr. Jaramillo wrote 15 Medicare Part D claims. 100% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $45 in total drug cost. In 2021, CMS named 1,630 claims across 53 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Jaramillo for performance year 2024, reported as part of a group. Dr. Jaramillo accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Dr. Jaramillo in 2014.

CMS Open Payments shows 16 general payments to Dr. Jaramillo from 7 drug and device companies from 2017 to 2021. Food and beverage make up the largest share, 100% of the total. Sunovion Pharmaceuticals Inc. paid the most, $173.